Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

SEPN

Septerna Inc

Oct 31 • 04:00PM ET

22.88

Dollar change +2.51
Percentage change 12.32	%

Healthcare • Biotechnology • USA • NASD

Held by: BMED

Index	-	P/E	-	EPS (ttm)	-	Insider Own	44.53%	Shs Outstand	42.00M	Perf Week	-
Market Cap	960.96M	Forward P/E	-	EPS next Y	-	Insider Trans	34.72%	Shs Float	23.30M	Perf Month	-
Income	-	PEG	-	EPS next Q	-	Inst Own	20.41%	Short Float	-	Perf Quarter	-
Sales	-	P/S	-	EPS this Y	-	Inst Trans	-	Short Ratio	-	Perf Half Y	-
Book/sh	-	P/B	-	EPS next Y	-	ROA	-	Short Interest	-	Perf Year	-
Cash/sh	-	P/C	-	EPS next 5Y	-	ROE	-	52W Range	18.62 - 25.62	Perf YTD	6.92%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-	52W High	-10.71%	Beta	-
Dividend TTM	-	Quick Ratio	-	Sales past 5Y	0.00%	Gross Margin	-	52W Low	22.88%	ATR (14)	2.72
Dividend Ex-Date	-	Current Ratio	-	EPS Y/Y TTM	-	Oper. Margin	-	RSI (14)	-	Volatility	- -
Employees	-	Debt/Eq	-	Sales Y/Y TTM	-	Profit Margin	-	Recom	-	Target Price	-
Option/Short	No / Yes	LT Debt/Eq	-	EPS Q/Q	-	Payout	-	Rel Volume	0.33	Prev Close	20.37
Sales Surprise	-	EPS Surprise	-	Sales Q/Q	-	Earnings	-	Avg Volume	1.05M	Price	22.88
SMA20	8.52%	SMA50	8.52%	SMA200	8.52%	Trades		Volume	347,353	Change	12.32%

Oct-30-24 04:41PM	Septerna Announces Closing of $331.2 Million Upsized Initial Public Offering (GlobeNewswire) +12.32%
Oct-24-24 09:47PM	Septerna Prices Upsized Initial Public Offering (GlobeNewswire)

Septerna, Inc. is a clinical-stage biotechnology company, which engages in pioneering a new era of G protein-coupled receptor oral small molecule drug discovery powered by proprietary Native Complex PlatformTM. Its pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic diseases. The company was founded by Robert Joseph Lefkowitz, Arthur Christopoulos, Patrick Sexton, and Jeffrey T. Finer in December 2019 and is headquartered in South San Francisco, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
RA CAPITAL MANAGEMENT, L.P.	Director	Oct 28 '24	Buy	18.00	4,170,000	75,060,000	5,523,915	Oct 30 06:12 PM
Third Rock Ventures V, L.P.	10% Owner	Oct 28 '24	Buy	18.00	370,500	6,669,000	6,215,591	Oct 28 04:53 PM
Third Rock Ventures V, L.P.	10% Owner	Oct 28 '24	Buy	18.00	279,500	5,031,000	3,152,456	Oct 28 04:53 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

SEPN

Septerna Inc

Upgrade your FINVIZ experience